PTEN knockdown alters dendritic spine/protrusion morphology, not density

Journal of Comparative Neurology

Volumn 522, Issue 5, 2014, Pages 1171-1190

  Haws, Michael E ^a,b   Jaramillo, Thomas C ^a   Espinosa, Felipe ^a   Widman, Allie ^a   Stuber, Garret D ^f,h   Sparta, Dennis R ^f   Tye, Kay M ^f,i   Russo, Scott J ^c   Parada, Luis F ^b   Stavarache, Mihaela ^d   Kaplitt, Michael ^d   Bonci, Antonello ^e,g   Powell, Craig M ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

ⁱ MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

AKT; Amygdale; Dendrite; Dentate gyrus; MTOR; PTEN; Spine

Indexed keywords

AKT; AMYGDALE; DENDRITE; DENTATE GYRUS; MTOR; PTEN; SPINE;

AMYGDALA; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CONDITIONING, CLASSICAL; DENDRITIC SPINES; GREEN FLUORESCENT PROTEINS; HIPPOCAMPUS; LOCOMOTION; MICE; MICE, TRANSGENIC; MINIATURE POSTSYNAPTIC POTENTIALS; MUTATION; NEURONS; ONCOGENE PROTEIN V-AKT; PHOSPHOPYRUVATE HYDRATASE; PTEN PHOSPHOHYDROLASE; STARTLE REACTION; TRANSDUCTION, GENETIC;

EID: 84893732333     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.23488     Document Type: Article

References (73)

1. Abel TW, Baker SJ, Fraser MM, Tihan T, Nelson JS, Yachnis AT, Bouffard JP, Mena H, Burger PC, Eberhart CG. 2005. Lhermitte-Duclos disease: a report of 31 cases with immunohistochemical analysis of the PTEN/AKT/mTOR pathway. J Neuropathol Exp Neurol 64:341-349.
2. Arellano JI, Benavides-Piccione R, Defelipe J, Yuste R. 2007. Ultrastructure of dendritic spines: correlation between synaptic and spine morphologies. Front Neurosci 1:131-143.
3. Backman SA, Stambolic V, Suzuki A, Haight J, Elia A, Pretorius J, Tsao MS, Shannon P, Bolon B, Ivy GO, Mak TW. 2001. Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nat Genet 29:396-403.
4. Bartlett JS, Samulski RJ, McCown TJ. 1998. Selective and rapid uptake of adeno-associated virus type 2 in brain. Hum Gene Ther 9:1181-1186.
5. Besson A, Robbins SM, Yong VW. 1999. PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis. Eur J Biochem 263:605-611.
6. Blundell J, Tabuchi K, Bolliger MF, Blaiss CA, Brose N, Liu X, Sudhof TC, Powell CM. 2009. Increased anxiety-like behavior in mice lacking the inhibitory synapse cell adhesion molecule neuroligin 2. Genes Brain Behav 8:114-126.
7. Blundell J, Kaeser PS, Sudhof TC, Powell CM. 2010. RIM1alpha and interacting proteins involved in presynaptic plasticity mediate prepulse inhibition and additional behaviors linked to schizophrenia. J Neurosci 30:5326-5333.
8. Boccone L, Dessi V, Zappu A, Piga S, Piludu MB, Rais M, Massidda C, De Virgiliis S, Cao A, Loudianos G. 2006. Bannayan-Riley-Ruvalcaba syndrome with reactive nodular lymphoid hyperplasia and autism and a PTEN mutation. Am J Med Genet 140:1965-1969.
9. Bourne J, Harris KM. 2007. Do thin spines learn to be mushroom spines that remember? Curr Opin Neurobiol 17:381-386.
10. Butler MG, Dasouki MJ, Zhou XP, Talebizadeh Z, Brown M, Takahashi TN, Miles JH, Wang CH, Stratton R, Pilarski R, Eng C. 2005. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet 42:318-321.
11. Buxbaum JD, Cai G, Chaste P, Nygren G, Goldsmith J, Reichert J, Anckarsater H, Rastam M, Smith CJ, Silverman JM, Hollander E, Leboyer M, Gillberg C, Verloes A, Betancur C. 2007. Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. Am J Med Genet B Neuropsychiatr Genet 144B:484-491.
12. Dahia PL. 2000. PTEN, a unique tumor suppressor gene. Endocr Relat Cancer 7:115-129.
13. Davis M, Rainnie D, Cassell M. 1994. Neurotransmission in the rat amygdala related to fear and anxiety. Trends Neurosci 17:208-214.
14. Di Cristofano A, Pandolfi PP. 2000. The multiple roles of PTEN in tumor suppression. Cell 100:387-390.
15. Dobrunz LE, Stevens CF. 1997. Heterogeneity of release probability, facilitation, and depletion at central synapses. Neuron 18:995-1008.
16. Downes CP, Bennett D, McConnachie G, Leslie NR, Pass I, MacPhee C, Patel L, Gray A. 2001. Antagonism of PI 3-kinase-dependent signalling pathways by the tumour suppressor protein, PTEN. Biochem Soc Trans 29:846-851.
17. Dumitriu D, Hao J, Hara Y, Kaufmann J, Janssen WG, Lou W, Rapp PR, Morrison JH. 2010. Selective changes in thin spine density and morphology in monkey prefrontal cortex correlate with aging-related cognitive impairment. J Neurosci 30:7507-7515.
18. Dumitriu D, Rodriguez A, Morrison JH. 2011. High-throughput, detailed, cell-specific neuroanatomy of dendritic spines using microinjection and confocal microscopy. Nat Protoc 6:1391-1411.
19. Dumitriu D, Berger SI, Hamo C, Hara Y, Bailey M, Hamo A, Grossman YS, Janssen WG, Morrison JH. 2012a. Vamping: stereology-based automated quantification of fluorescent puncta size and density. J Neurosci Methods 209:97-105.
20. Dumitriu D, Laplant Q, Grossman YS, Dias C, Janssen WG, Russo SJ, Morrison JH, Nestler EJ. 2012b. Subregional, dendritic compartment, and spine subtype specificity in cocaine regulation of dendritic spines in the nucleus accumbens. J Neurosci 32:6957-6966.
21. Encinas JM, Vaahtokari A, Enikolopov G. 2006. Fluoxetine targets early progenitor cells in the adult brain. Proc Natl Acad Sci U S A 103:8233-8238.
22. Eng C. 1999. The role of PTEN, a phosphatase gene, in inherited and sporadic nonmedullary thyroid tumors. Recent Prog Horm Res 54:441-452; discussion 453.
23. Eng C. 2003. PTEN: one gene, many syndromes. Hum Mutat 22:183-198.
24. Fiala JC, Allwardt B, Harris KM. 2002. Dendritic spines do not split during hippocampal LTP or maturation. Nat Neurosci 5:297-298.
25. Forster MD, Dedes KJ, Sandhu S, Frentzas S, Kristeleit R, Ashworth A, Poole CJ, Weigelt B, Kaye SB, Molife LR. 2011. Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer. Nat Rev Clin Oncol 8:302-306.
26. Fraser MM, Bayazitov IT, Zakharenko SS, Baker SJ. 2008. Phosphatase and tensin homolog, deleted on chromosome 10 deficiency in brain causes defects in synaptic structure, transmission and plasticity, and myelination abnormalities. Neuroscience 151:476-488.
27. Goffin A, Hoefsloot LH, Bosgoed E, Swillen A, Fryns JP. 2001. PTEN mutation in a family with Cowden syndrome and autism. Am J Med Genet 105:521-524.
28. Govindarajan A, Rao BS, Nair D, Trinh M, Mawjee N, Tonegawa S, Chattarji S. 2006. Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects. Proc Natl Acad Sci U S A 103:13208-13213.
29. Hao J, Rapp PR, Leffler AE, Leffler SR, Janssen WG, Lou W, McKay H, Roberts JA, Wearne SL, Hof PR, Morrison JH. 2006. Estrogen alters spine number and morphology in prefrontal cortex of aged female rhesus monkeys. J Neurosci 26:2571-2578.
30. Harris KM, Stevens JK. 1989. Dendritic spines of CA 1 pyramidal cells in the rat hippocampus: serial electron microscopy with reference to their biophysical characteristics. J Neurosci 9:2982-2997.
31. Herman GE, Butter E, Enrile B, Pastore M, Prior TW, Sommer A. 2007. Increasing knowledge of PTEN germline mutations: two additional patients with autism and macrocephaly. Am J Med Genet 143:589-593.
32. Hobert JA, Eng C. 2009. PTEN hamartoma tumor syndrome: an overview. Genet Med 11:687-694.
33. Hoeffer CA, Klann E. 2010. mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci 33:67-75.
34. Johnson LR, Hou M, Ponce-Alvarez A, Gribelyuk LM, Alphs HH, Albert L, Brown BL, Ledoux JE, Doyere V. 2008. A recurrent network in the lateral amygdala: a mechanism for coincidence detection. Front Neural Circuits 2:3.
35. Kwon CH, Zhu X, Zhang J, Knoop LL, Tharp R, Smeyne RJ, Eberhart CG, Burger PC, Baker SJ. 2001. Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease. Nat Genet 29:404-411.
36. Kwon CH, Zhu X, Zhang J, Baker SJ. 2003. mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo. Proc Natl Acad Sci U S A 100:12923-12928.
37. Kwon CH, Luikart BW, Powell CM, Zhou J, Matheny SA, Zhang W, Li Y, Baker SJ, Parada LF. 2006. Pten regulates neuronal arborization and social interaction in mice. Neuron 50:377-388.
38. Lakshminarasimhan H, Chattarji S. 2012. Stress leads to contrasting effects on the levels of brain derived neurotrophic factor in the hippocampus and amygdala. PloS One 7:e30481.
39. LeDoux J. 2007. The amygdala. Curr Biol 17:R868-874.
40. Leslie NR, Downes CP. 2002. PTEN: The down side of PI 3-kinase signalling. Cell Signal 14:285-295.
41. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R. 1997. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943-1947.
42. Luikart BW, Schnell E, Washburn EK, Bensen AL, Tovar KR, Westbrook GL. 2011. Pten knockdown in vivo increases excitatory drive onto dentate granule cells. J Neurosci 31:4345-4354.
43. Maehama T, Dixon JE. 1998. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3, 4, 5-trisphosphate. J Biol Chem 273:13375-13378.
44. Maehama T, Dixon JE. 1999. PTEN: a tumour suppressor that functions as a phospholipid phosphatase. Trends Cell Biol 9:125-128.
45. Matsuo N, Reijmers L, Mayford M. 2008. Spine-type-specific recruitment of newly synthesized AMPA receptors with learning. Science 319:1104-1107.
46. McBride KL, Varga EA, Pastore MT, Prior TW, Manickam K, Atkin JF, Herman GE. 2010. Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly. Autism Res 3:137-141.
47. McDonald AJ. 1982. Neurons of the lateral and basolateral amygdaloid nuclei: a Golgi study in the rat. J Comp Neurol 212:293-312.
48. McIlwain KL, Merriweather MY, Yuva-Paylor LA, Paylor R. 2001. The use of behavioral test batteries: effects of training history. Physiol Behav 73:705-717.
49. Moldrich RX, Gobius I, Pollak T, Zhang J, Ren T, Brown L, Mori S, De Juan Romero C, Britanova O, Tarabykin V, Richards LJ. 2010. Molecular regulation of the developing commissural plate. J Comp Neurol 518:3645-3661.
50. Moult PR, Cross A, Santos SD, Carvalho AL, Lindsay Y, Connolly CN, Irving AJ, Leslie NR, Harvey J. 2010. Leptin regulates AMPA receptor trafficking via PTEN inhibition. J Neurosci 30:4088-4101.
51. Mullen RJ, Buck CR, Smith AM. 1992. NeuN, a neuronal specific nuclear protein in vertebrates. Development 116:201-211.
52. Nelen MR, van Staveren WC, Peeters EA, Hassel MB, Gorlin RJ, Hamm H, Lindboe CF, Fryns JP, Sijmons RH, Woods DG, Mariman EC, Padberg GW, Kremer H. 1997. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet 6:1383-1387.
53. Nusser Z, Lujan R, Laube G, Roberts JD, Molnar E, Somogyi P. 1998. Cell type and pathway dependence of synaptic AMPA receptor number and variability in the hippocampus. Neuron 21:545-559.
54. Orloff MS, Eng C. 2008. Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome. Oncogene 27:5387-5397.
55. Orrico A, Galli L, Buoni S, Orsi A, Vonella G, Sorrentino V. 2009. Novel PTEN mutations in neurodevelopmental disorders and macrocephaly. Clin Genet 75:195-198.
56. Paylor R, Spencer CM, Yuva-Paylor LA, Pieke-Dahl S. 2006. The use of behavioral test batteries, II: effect of test interval. Physiol Behav 87:95-102.
57. Powell CM, Schoch S, Monteggia L, Barrot M, Matos MF, Feldmann N, Sudhof TC, Nestler EJ. 2004. The presynaptic active zone protein RIM1alpha is critical for normal learning and memory. Neuron 42:143-153.
58. Pun RY, Rolle IJ, Lasarge CL, Hosford BE, Rosen JM, Uhl JD, Schmeltzer SN, Faulkner C, Bronson SL, Murphy BL, Richards DA, Holland KD, Danzer SC. 2012. Excessive activation of mTOR in postnatally generated granule cells is sufficient to cause epilepsy. Neuron 75:1022-1034.
59. Rodriguez A, Ehlenberger DB, Hof PR, Wearne SL. 2006. Rayburst sampling, an algorithm for automated three-dimensional shape analysis from laser scanning microscopy images. Nat Protoc 1:2152-2161.
60. Rodriguez A, Ehlenberger DB, Dickstein DL, Hof PR, Wearne SL. 2008. Automated three-dimensional detection and shape classification of dendritic spines from fluorescence microscopy images. PloS One 3:e1997.
61. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV. 1997. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:356-362.
62. Stein MT, Elias ER, Saenz M, Pickler L, Reynolds A. 2010. Autistic spectrum disorder in a 9-year-old girl with macrocephaly. J Dev Behav Pediatr 31:632-634.
63. Stuber GD, Sparta DR, Stamatakis AM, van Leeuwen WA, Hardjoprajitno JE, Cho S, Tye KM, Kempadoo KA, Zhang F, Deisseroth K, Bonci A. 2011. Excitatory transmission from the amygdala to nucleus accumbens facilitates reward seeking. Nature 475:377-380.
64. Suzuki A, Yamaguchi MT, Ohteki T, Sasaki T, Kaisho T, Kimura Y, Yoshida R, Wakeham A, Higuchi T, Fukumoto M, Tsubata T, Ohashi PS, Koyasu S, Penninger JM, Nakano T, Mak TW. 2001. T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 14:523-534.
65. Tabuchi K, Blundell J, Etherton MR, Hammer RE, Liu X, Powell CM, Sudhof TC. 2007. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318:71-76.
66. Varga EA, Pastore M, Prior T, Herman GE, McBride KL. 2009. The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly. Genet Med 11:111-117.
67. Vazquez F, Sellers WR. 2000. The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling. Biochim Biophys Acta 1470:M21-35.
68. Waite KA, Eng C. 2002. Protean PTEN: form and function. Am J Hum Genet 70:829-844.
69. Wearne SL, Rodriguez A, Ehlenberger DB, Rocher AB, Henderson SC, Hof PR. 2005. New techniques for imaging, digitization and analysis of three-dimensional neural morphology on multiple scales. Neuroscience 136:661-680.
70. Xiong Q, Oviedo HV, Trotman LC, Zador AM. 2012. PTEN Regulation of local and long-range connections in mouse auditory cortex. J Neurosci 32:1643-1652.
71. Zhang XC, Piccini A, Myers MP, Van Aelst L, Tonks NK. 2012. Functional analysis of the protein phosphatase activity of PTEN. Biochem J 444:457-464.
72. Zhou J, Blundell J, Ogawa S, Kwon CH, Zhang W, Sinton C, Powell CM, Parada LF. 2009. Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice. J Neurosci 29:1773-1783.
73. Zori RT, Marsh DJ, Graham GE, Marliss EB, Eng C. 1998. Germline PTEN mutation in a family with Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome. Am J Med Genet 80:399-402.